Evaluation of combined or separate automatic segmentation models for 68Ga-PSMA PET/CT and 177Lu-PSMA SPECT/CT

被引：0
|
作者：
Decazes, P. [1 ]
Perret, S. [1 ]
Albe, L. [1 ]
Tonnelet, D. [1 ]
Mesbah, Z. [1 ]
Modzelewski, R. [1 ]
Bohn, P. [1 ]
Vera, P. [1 ]
Edet-Sanson, A. [1 ]
Dieudonne, A. [1 ]
机构：
[1] Henri Becquerel Canc Ctr, Rouen, France
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0863
引用
收藏
页码：S776 / S776
页数：1
相关论文
共 50 条
  • [31] PET/CT with 68Ga-PSMA for monitoring the treatment of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer
    Heinzel, A.
    Boghos, D.
    Mottaghy, F. M.
    Gaertner, F.
    Essler, M.
    von Mallek, D.
    Ahmadzadehfar, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S23 - S23
  • [32] 68Ga-PSMA PET/CT in the evaluation of bone metastases in prostate cancer
    Christos Sachpekidis
    P. Bäumer
    K. Kopka
    B. A. Hadaschik
    M. Hohenfellner
    A. Kopp-Schneider
    U. Haberkorn
    A. Dimitrakopoulou-Strauss
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 904 - 912
  • [33] 68Ga-PSMA PET/CT in the evaluation of bone metastases in prostate cancer
    Sachpekidis, Christos
    Baeumer, P.
    Kopka, K.
    Hadaschik, B. A.
    Hohenfellner, M.
    Kopp-Schneider, A.
    Haberkorn, U.
    Dimitrakopoulou-Strauss, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (06) : 904 - 912
  • [34] Harmonisation of Serial 177Lu-PSMA SPECT/CT Images in Patients with Metastatic Castrate-Resistant Prostate Cancer Treated with 177Lu-PSMA-617: A Prospective Multicentre 177Lu-PSMA SPECT/CT harmonisation (ENZA-p)
    Ayati, N.
    Hioki, T.
    van Oorschodt, J. C. J.
    McGill, G.
    Marquis, H.
    Francis, R.
    Bailey, D.
    Eslick, E.
    Sandhu, S.
    Davis, I. D.
    Stockler, M.
    Subramaniam, S.
    Crumbaker, M.
    Subhash, V.
    Sharma, S.
    Ayers, M.
    Jackson, P.
    Emmett, L.
    Willowson, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S280 - S281
  • [35] Comparison of 68Ga-PSMA and 177Lu-PSMA Total Metabolic Tumor Volume (TMTV) variations for monitoring metastatic castration-resistant prostate cancer in 177Lu-PSMA therapy.
    Boursier, C.
    Zaragori, T.
    Kunsch, J.
    Olivier, P.
    Claudin, M.
    Marie, P.
    Bros, M.
    Bordonne, M.
    Verger, A.
    Karcher, G.
    Imbert, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S361 - S362
  • [36] Synchronous Paraganglioma Masquerading as 68Ga-PSMA PET/CT-Avid Metastasis in Carcinoma Prostate-How Specific Is 68Ga-PSMA PET/CT?
    Tyagi, Shantanu
    Singh, Shrawan Kumar
    Narain, Tushar Aditya
    Singh, Harmandeep
    Kumar, Rajender
    Vadi, Shelvin Kumar
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (06) : E420 - E422
  • [37] 177Lu-PSMA Therapy Response Prediction in Metastatic Prostate Cancer Patients by Textural Heterogeneity Parameters in Baseline 68Ga-PSMA PET Scans
    Khurshid, Z.
    Ahmadzadehfar, H.
    Gaertner, F. C.
    Papp, L.
    Zsoter, N.
    Strunk, H.
    Essler, M.
    Bundschuh, R. A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S280 - S280
  • [38] 99mTc-PSMA offers diagnostic accuracy comparable to 68Ga-PSMA PET for planning 177Lu-PSMA therapy in advanced stage prostate cancer patients
    Hooda, Monika
    Singh, Baljinder
    Singh, Shrawan Kumar
    Kakkar, Nandita
    Mavuduru, Ravimohan
    Singh, Harmandeep
    Sharma, Aditya
    Prashar, Sarika
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [39] Incidental Detection of Splenic Hemangioma on 68Ga-PSMA PET/CT
    Sheng, Kevin
    Le, Ken
    Bui, Chuong
    Mansberg, Robert
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (10) : 821 - 823
  • [40] Incidental identification of osteoid osteoma by 68Ga-PSMA PET/CT
    Castello, Angelo
    Lopci, Egesta
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (03) : 509 - 510
12345